Expression of MxA protein in blood lymphocytes of children receiving anticancer chemotherapy

Pediatric Hematology and Oncology

Volumn 23, Issue 8, 2006, Pages 649-660

  Koskenvuo, Minna M ^a,d   Halminen, Markus ^a   Blomqvist, Miia ^a   Vainionpää, Raija ^a   Ilonen, Jorma ^a   Julkunen, Ilkka ^b   Salmi, Toivo T ^a   Mäkelä, Mika J ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cancer; Chemotherapy; Children; Fever of unknown origin; MxA protein

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; C REACTIVE PROTEIN; CYTARABINE; METHOTREXATE; MYXOVIRUS RESISTANCE PROTEIN A;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISEASE SUSCEPTIBILITY; FEMALE; FEVER; GTP-BINDING PROTEINS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-ALPHA; LYMPHOCYTES; MALE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; VIRUS DISEASES;

EID: 33750479059     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010600956863     Document Type: Article

References (31)

1. Krance RA, Newman EM, Ravindranath Y. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer. 1991;67:550-556.
2. Mäkelä MJ, Ruuskanen O, Ogra PL. Treatment of respiratory syncytial virus infections in children. Ann Med. 1994;26:341-343.
3. Arola M, Ruuskanen O, Ziegler T, Salmi TT. Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J. 1995;14:690-694.
4. Möttönen M, Uhari M, Lanning M, Tuokko H. Prospective controlled survey of viral infections in children with acute lymphoblastic leukemia during chemotherapy. Cancer. 1995;75:1712-1717.
5. Nishimura K, Nagamoto A, Igarashi M. Extensive skin manifestations of herpesvirus infection in an acute leukemic child. Pediatrics. 1972;49:294-297.
6. Putto A, Meurman O, Ruuskanen O. C-reactive protein in the differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsillitis in children. Eur J Pediatr. 1986;145:204-206.
7. Putto A, Ruuskanen O, Meurman O. C reactive protein in the evaluation of febrile illness. Arch Dis Child. 1986;61:24-29.
8. Riikonen P, Jalanko H, Hovi L, Saarinen UM. Fever and neutropenia in children with cancer: diagnostic parameters at presentation. Acta Paediatr. 1993;82:271-275.
9. Putto A, Ruuskanen O, Meurman O. Fever in respiratory virus infections. Am J Dis Child. 1986;140:1159-1163.
10. Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, Mäkelä MJ. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res. 1997;41:647-650.
11. Forster J, Schweizer M, Schumacher RF, Kaufmehl K, Lob S. MxA protein in infants and children with respiratory tract infection. Acta Paediatr. 1996;85:163-167.
12. Chieux V, Hober D, Harvey J. The MxA protein levels in whole blood lysates of patients with various viral infections. J Virol Methods. 1998;70:183-191.
13. Aebi M, Fah J, Hurt N, et al. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol. 1989;9:5062-5072.
14. von Wussow P, Jakschies D, Hochkeppel HK, Fibich C, Penner L, Deicher H. The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur J Immunol. 1990;20:2015-2019.
15. Simon A, Fah J, Haller O, Staeheli P. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol. 1991;65:968-971.
16. Ronni T, Melen K, Malygin A, Julkunen I. Control of IFN-inducible MxA gene expression in human cells. J Immunol. 1993;150:1715-1726.
17. Arola A, Kallajoki M, Ruuskanen O, Hyypiä T. Detection of enteroviral RNA in end-stage dilated cardiomyopathy in children and adolescents. J Med Virol. 1998;56:364-371.
18. Hyypiä T, Puhakka T, Ruuskanen O, Mäkelä M, Arola A, Arstila P. Molecular diagnosis of human rhinovirus infections: comparison with virus isolation. J Clin Microbiol. 1998;36:2081-2083.
19. Mäkelä MJ, Halminen M, Ruuskanen O, et al. Rhinoviruses do not induce type I interferon production or enhanced MxA protein expression during common cold. Eur J Clin Microb Inf Dis. 1999;18:665-668.
20. Mäkelä MJ, Puhakka T, Ruuskanen O. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539-542.
21. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis. 1994;26:77-84.
22. Rump JA, Jakschiess D, Walker U, Schlesier M, von Wussow P, Peter HH. Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes. Clin Exp Immunol. 1995;101:89-93.
23. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med. 1999;159:1199-1204.
24. Lie SO, Gustafsson G. Progress in the treatment of childhood leukaemias. Ann Med. 1992;24:319-323.
25. Hayes FA, Green AA. Neuroblastoma Pediatr Ann. 1983;12:370-373.
26. Anderson JR, Wilson JF, Jenkin DT. Childhood non-Hodgkin's lymphoma: the results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 1983;308:559-565.
27. Gobbi PG, Pieresca C, Ghirardelli ML. Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease. Blood. 1998;91:2704-2712.
28. Basso G, Perilongo G, Pontisso P, Pritchard J, Plaschkes J. Childhood Liver Tumor Tissue Storage Programme: SIOP liver tumor study iniative. Med Pediatr Oncol. 1994;22:425-427.
29. Green DM, Thomas PR, Shochat S. The treatment of Wilms tumor: results of the National Wilms Tumor Studies. Hematol Oncol Clin North Am. 1995;9:1267-1274.
30. Erttmann R, Tafese T, Berthold F. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE). Eur J Cancer. 1998;34:1391-1397.
31. Einhorn LH, Williams SD. Chemotherapy of disseminated testicular cancer: a random prospective study. Cancer. 1980;46:1339-1344.